SCHEMBL6430899

SCHEMBL6430899

CC1(OC(=O)/C=C\C(=O)OC2(C)CCCCO2)CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27552918 0.86 TSHR (0.32)
SCHEMBL10875348 0.81 FFAR3 (0.30)
SCHEMBL4365632 0.80 TSHR (0.32)
SCHEMBL246034 0.79
SCHEMBL10875212 0.78 NPSR1 (0.32)
SCHEMBL10667942 0.77
SCHEMBL28906906 0.76 TSHR (0.36)
SCHEMBL28017556 0.76 GLS (0.31)
SCHEMBL11246635 0.75 FFAR3 (0.31)
SCHEMBL11248378 0.75 FFAR3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1321140-B1 IBUPROFEN SOLUTIONS FOR CAPSULE-FILLING AND CAPSULE PREPARATIONS KOWA CO (JP) 2005-04-06 EP disclosed
US-20030187070-A1 Ibuprofen solutions for capsule-filling and capsule preparations KOWA COMPANY, LTD. (JP) 2003-10-02 US disclosed
EP-1321140-A1 IBUPROFEN SOLUTIONS FOR CAPSULE-FILLING AND CAPSULE PREPARTIONS KOWA COMPANY, LTD. (JP) 2003-06-25 EP disclosed